Program
 |
Monday , March 5th
08.00
Registration and Exhibition hall Opens
09.00-10.00
Welcome and Opening Remarks
Sigal Weisswasser- President & C.E.O, The T.B.N. Group
Yona Yahav - Mayor, Municipality of Haifa
Prof. Daniel Shechtman - Nobel Prize Laureate for 2011 in Chemistry
Shmuel Gants- Director General, Municipality of Haifa
Sigal Weisswasser- President & C.E.O, The T.B.N. Group
Yona Yahav - Mayor, Municipality of Haifa
Prof. Daniel Shechtman - Nobel Prize Laureate for 2011 in Chemistry
Shmuel Gants- Director General, Municipality of Haifa
10.00 -11.15
Opening Plenary session
The VC - Medtech, Biopharma future relationship / Minding the Gap
How best to communicate value and manage expectations – Investors and BioMed executives debate the state of their relationship and whether shareholders now bear most of the risk without due financial rewards
Moderator: Sigal Weisswasser - President & CEO , The T.B.N. Group
Yehuda Zisapel - President of Rad Group , investor & entrepreneur
Anthony Viscogliosi - Chairmen of VB, LLC
Dr. Pennina Safer – VP , Medica Venture Partners
Dr. Ilan Cohn- Senior Partner, Patent Attorney, Head of Life Science & Chemistry Dept.,
Reinhold Cohn Group
The VC - Medtech, Biopharma future relationship / Minding the Gap
How best to communicate value and manage expectations – Investors and BioMed executives debate the state of their relationship and whether shareholders now bear most of the risk without due financial rewards
Moderator: Sigal Weisswasser - President & CEO , The T.B.N. Group
Yehuda Zisapel - President of Rad Group , investor & entrepreneur
Anthony Viscogliosi - Chairmen of VB, LLC
Dr. Pennina Safer – VP , Medica Venture Partners
Dr. Ilan Cohn- Senior Partner, Patent Attorney, Head of Life Science & Chemistry Dept.,
Reinhold Cohn Group
11.15 -12.30
Panel discussion
Creating Deal and Business Models with Faster Return in mind
Moderator: Christian Suojanen - Director , Global Life Sciences, Valor Management, and Co-Chairman Tech Transfer Initiative (TTS Ltd)
Dr. Jeroen Tonnaer – Senior Director, Head European Team External
Scientific Affairs Worldwide Licensing, MSD
Umberto Pasquali - VP Finance & Business Development , Sorin Group
Gwen A. Melincoff - SVP, Business Development ,Strategic Investment Group Shire Pharmaceuticals
Dr. Ilan Cohn- Senior Partner, Patent Attorney, Head of Life Science &Chemistry Dept., Reinhold Cohn Group
Creating Deal and Business Models with Faster Return in mind
Moderator: Christian Suojanen - Director , Global Life Sciences, Valor Management, and Co-Chairman Tech Transfer Initiative (TTS Ltd)
Dr. Jeroen Tonnaer – Senior Director, Head European Team External
Scientific Affairs Worldwide Licensing, MSD
Umberto Pasquali - VP Finance & Business Development , Sorin Group
Gwen A. Melincoff - SVP, Business Development ,Strategic Investment Group Shire Pharmaceuticals
Dr. Ilan Cohn- Senior Partner, Patent Attorney, Head of Life Science &Chemistry Dept., Reinhold Cohn Group
12.30 -13.30
Networking Lunch
13.30 - 17.30
Parallel Panel discussions and Spotlight Tracks
13.30 - 15.00
Spotlight Track
13.30- 14.00
How to dance with the large Pharma players today
Moderator: Dr. Jeroen Tonnaer – Head of European Team External Scientific Affairs Worldwide Licensing, MSD
Moderator: Dr. Jeroen Tonnaer – Head of European Team External Scientific Affairs Worldwide Licensing, MSD
14.00- 14.30
Unconventional partnership models in today's market
Moderator: Anthony Viscogliosi - Chairmen of VB, LLC
Moderator: Anthony Viscogliosi - Chairmen of VB, LLC
14.30- 15.00
Best Practices after the first Venture round
Moderator: Anat Naschitz - Partner, OrbiMed Advisors , Global Lifescience investment firm
Moderator: Anat Naschitz - Partner, OrbiMed Advisors , Global Lifescience investment firm
15.00- 16.00
Companies Presentations Medtech /BioPharma
16.00-16.45
Panel Discussion
HealthCare & Business: Where the medical world is heading to and technologies that will shape the future
Moderator: Zeev Zelig , VP; GM Israel , Genzyme Pharmaceuticals
Oded Meirav - Director , Israel Technology Center, GE Global Research
Dr. Ezekiel Guy - GM/VP, Medtronic Ventor
Professor Rafi Beyar - Director Rambam Health Care Campus
Marijana Golubovic- Director Business Development, DSM Biologics B.V.
HealthCare & Business: Where the medical world is heading to and technologies that will shape the future
Moderator: Zeev Zelig , VP; GM Israel , Genzyme Pharmaceuticals
Oded Meirav - Director , Israel Technology Center, GE Global Research
Dr. Ezekiel Guy - GM/VP, Medtronic Ventor
Professor Rafi Beyar - Director Rambam Health Care Campus
Marijana Golubovic- Director Business Development, DSM Biologics B.V.
16.45-17.30
Financial Track
Alternative finance in today's market
A perfect Partnering with a Financial Company
Moderator: Dr. Jacob Dagan- Head of Life Science , Migdal Underwriting and Business Initiatives Ltd.
How can Biotech companies benefit from alternative funding strategies?
Moderator: Johan Ohlsson- Partner, Venture Valuation
Financial Opportunities through International R&D Cooperation
Moderator: Michel Hivert - Managing Director, MATIMOP- The Israeli Industry Center for R&D
Alternative finance in today's market
A perfect Partnering with a Financial Company
Moderator: Dr. Jacob Dagan- Head of Life Science , Migdal Underwriting and Business Initiatives Ltd.
How can Biotech companies benefit from alternative funding strategies?
Moderator: Johan Ohlsson- Partner, Venture Valuation
Financial Opportunities through International R&D Cooperation
Moderator: Michel Hivert - Managing Director, MATIMOP- The Israeli Industry Center for R&D
17.30 - 20.00
Cocktail Reception at The National Maritime Museum, Hosted by Municipality of Haifa
Tuesday , March 6th
08:00
Registration and Exhibition hall Opens
9.00 -9.45
Keynote Discussions on Leadership:
What type of DNA do CEO's need today?
With uncertain market and investors pushing for exits, the pressure is on CEOs to develop companies for sale, not to build companies. Investors and executives discuss what is needed in today's marketplace for CEO to succeed and move forward
Moderator: Gali Weinreb- Healthcare correspondent, Globes
David Tsur - President , Kamada Biopharmaceutical
Karen Sarid - President , Alma Lazers
Yehiel Tal - C.E.O , Collplant Biotechnology
Miki Blumenthal-Partner, Fahn Kanne & Co, Grant Thornton
What type of DNA do CEO's need today?
With uncertain market and investors pushing for exits, the pressure is on CEOs to develop companies for sale, not to build companies. Investors and executives discuss what is needed in today's marketplace for CEO to succeed and move forward
Moderator: Gali Weinreb- Healthcare correspondent, Globes
David Tsur - President , Kamada Biopharmaceutical
Karen Sarid - President , Alma Lazers
Yehiel Tal - C.E.O , Collplant Biotechnology
Miki Blumenthal-Partner, Fahn Kanne & Co, Grant Thornton
One to One
Partnering Meetings
Partnering Meetings
9.45- 12.40
Companies Presentations Medtech /BioPharma
12.30 -13.30
Networking Lunch
13.30 -14.15
Workshop
Recognizing and avoiding Mistakes that Can Cost you the Deal
Moderator: Diane Romaz - Kutz, Partner, Troutman Sanders
Recognizing and avoiding Mistakes that Can Cost you the Deal
Moderator: Diane Romaz - Kutz, Partner, Troutman Sanders
14.15- 16.15
M&A , Investments and Licensing Track
14.15-14.35
Noam Gavish - Partner, Ben-Dror, Stretiner, Baruch, Gavish Law Offices
The commercial aspects of a Licensing deal
The commercial aspects of a Licensing deal
14.35-14.55
Klaus Nestler - C.E.O , Corporate Finance Partners AG
Investment banking – A new Channel for fund raising
Investment banking – A new Channel for fund raising
14.55-15.15
Ilana Odess - Partner , Founder & Managing partner , VB IOTA
Dancing with Giants
Dancing with Giants
15.15-15.35
Shelly Kraft - Membership Chairman, The National Investment Banking Association (USA)
Making the best choice- Going public or staying private
Making the best choice- Going public or staying private
15.35- 15.55
Zeev Weiss- Executive VP, Commercial Operational, IntecPharma
Becoming a Public Biomed firm in TASE as a Successful FundingApproachh
Becoming a Public Biomed firm in TASE as a Successful FundingApproachh
Zeev Weiss- Executive VP, Commercial Operational, IntecPharma
15.55-16.15
Dr. Moti Levi – C.E.O, Life Group, LLC
A New Model for Venture Investments: Applying the Buffet Principles
A New Model for Venture Investments: Applying the Buffet Principles
16.15- 17.00
Panel discussion
Investments, M&A and Business in China – How does it work?
Moderator: Sigal Weisswasser - President & CEO , The T.B.N. Group
Dr. Bella Ohana - Managing Director, Infinity VC
Esther Koren - Head of M&A department, GKH Law office
Investments, M&A and Business in China – How does it work?
Moderator: Sigal Weisswasser - President & CEO , The T.B.N. Group
Dr. Bella Ohana - Managing Director, Infinity VC
Esther Koren - Head of M&A department, GKH Law office
Mr. Wu Jianfeng - Vice president of China national, President of Import & export division, Sinopharm, China
17.00- 18.00
Closing Network Cocktail
Wednesday , March 7th
8.30 – 16.00
Walk the Path of History
Complimentary Tour in Northern Israel Hosted by Municipality of Haifa
read more
Complimentary Tour in Northern Israel Hosted by Municipality of Haifa
read more
*kindly note that Due to the nature of the conference changes may occur with no further notice
|
Partnering Meetings